Anti-Helicobacter pylori effects of IgY from egg york of immunized hens

• Published in: Laboratory animal research 2012, 28(1), , pp.55-60
• Main Authors: Yang, Y.H., Chungbuk National University, Cheongju, Republic of Korea, Park, D.S., Chungbuk National University, Cheongju, Republic of Korea, Yang, G.E., Chungbuk National University, Cheongju, Republic of Korea, Lee, S.H., Chungbuk National University, Cheongju, Republic of Korea, Bae, D.K., Chungbuk National University, Cheongju, Republic of Korea, Kyung, J.B., Chungbuk National University, Cheongju, Republic of Korea, Kim, D.J., Chungbuk National University, Cheongju, Republic of Korea, Choi, E.K., Chungbuk National University, Cheongju, Republic of Korea, Son, J.C., Chungbuk National University Hospital, Cheongju, Republic of Korea, Hwang, S.Y., Daejeon University, Daejeon, Republic of Korea, Kim, Y.B., Chungbuk National University, Cheongju, Republic of Korea
• Format: Article
• Language: English
• Subjects: CLO test; gastric inflammation; HELICOBACTER PYLORI; immunoglobulin Y; minimal inhibitory concentration; Original; 수의학
• ISSN: 1738-6055; 2233-7660
• DOI: 10.5625/lar.2012.28.1.55

Effects of egg york containing IgY specific for Helicobacter pylori on the bacterial growth and intragastric infection were investigated in comparison with a proton-pump inhibitor pantoprazole. For in vitro antibacterial activity test, H. pylori (1×10∨8 CFU/mL) was incubated with a serially diluted IgY for 3 days. As a result, IgY fully inhibited the bacterial growth at 16 mg/mL, which was determined to a minimal inhibitory concentration. In vivo elimination study, male C57BL/6 mice were infected with the bacteria by intragastric inoculation (1×10∨8 CFU/mouse) 3 times at 2-day intervals, and 2 weeks later, orally treated twice a day with 50, 100, 200 or 500 mg/kg IgY for 18 days. After the final administration, biopsy sample of the gastric mucosa was assayed for the bacterial identification via urease, oxidase, catalase, nitrate reduction and H₂S tests in addition to microscopic examination for mucosal inflammation. In CLO kit test, 75, 50, 12.5 and 12.5% of the animals revealed positive reaction following treatment with 50, 100, 200 and 500 mg/kg IgY, respectively, resulting in a superior efficacy at 200 mg/kg than 30 mg/kg pantoprazole that displayed 75% elimination. The CLO test results were confirmed by bacterial identification. Microscopic examination revealed that H. pylori infection caused severe gastric mucosal inflammation, which were not observed in the CLO-negative mice following treatment with IgY or pantoprazole. Taken together, IgY inhibited the growth of H. pylori, and improved gastritis and villi injuries by eliminating the bacteria from the stomach. The results indicate that IgY could be a good candidate overcoming tolerance of antibiotics for the treatment of H. pylori-mediated gastric ulcers.